| [1] | Reichman T.W., Markmann J.F., Odorico J., et al. (2025). Stem cell-derived, fully differentiated islets for type 1 diabetes. N. Engl. J. Med. Online ahead of print. DOI:10.1056/NEJMoa2506549 |
| [2] | Ramzy A., Thompson D.M., Ward-Hartstonge K.A., et al. (2021). Implanted pluripotent stem-cell-derived pancreatic endoderm cells secrete glucose-responsive C-peptide in patients with type 1 diabetes. Cell Stem Cell 28:2047−2061.e5. DOI:10.1016/j.stem.2021.10.003 |
| [3] | Keymeulen, B., De Groot, K., Jacobs-Tulleneers-Thevissen, D., et al. (2024). Encapsulated stem cell-derived beta cells exert glucose control in patients with type 1 diabetes. Nat. Biotechnol. 42:1507−1514. DOI:10.1038/s41587-023-02055-5 |
| [4] | Wang S., Du Y., Zhang B., et al. (2024). Transplantation of chemically induced pluripotent stem-cell-derived islets under abdominal anterior rectus sheath in a type 1 diabetes patient. Cell 187:6152−6164.e18. DOI:10.1016/j.cell.2024.09.004 |
| [5] | Wu J., Li T., Guo M., et al. (2024). Treating a type 2 diabetic patient with impaired pancreatic islet function by personalized endoderm stem cell-derived islet tissue. Cell Discov. 10:45. DOI:10.1038/s41421-024-00662-3 |
| Dong L., Cao X., Mi C., et al. (2025). Stem cell-derived islets — significant progress amidst ongoing challenges for type 1 diabetes. The Innovation Medicine 3:100149. https://doi.org/10.59717/j.xinn-med.2025.100149 |
To request copyright permission to republish or share portions of our works, please visit Copyright Clearance Center's (CCC) Marketplace website at marketplace.copyright.com.
Therapeutic journey of stem cell-derived islets for type 1 diabetes